Gene: ZNF573
Official Full Name: zinc finger protein 573provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27417 | ZNF573 Knockout cell line (HeLa) | Human | ZNF573 | 1:3~1:6 | Negative | Online Inquiry |
KO27418 | ZNF573 Knockout cell line (HCT 116) | Human | ZNF573 | 1:2~1:4 | Negative | Online Inquiry |
KO27419 | ZNF573 Knockout cell line (HEK293) | Human | ZNF573 | 1:3~1:6 | Negative | Online Inquiry |
KO27420 | ZNF573 Knockout cell line (A549) | Human | ZNF573 | 1:3~1:4 | Negative | Online Inquiry |
ZNF573 Gene Knockout Cell Lines are a specialized product designed to facilitate in-depth research into the function of the ZNF573 gene, which encodes a zinc finger protein implicated in various biological processes, including gene regulation and cellular differentiation. These cell lines have been engineered using CRISPR/Cas9 technology to create precise deletions in the ZNF573 gene, allowing researchers to study the phenotypic consequences of gene knockout on cellular behavior and signaling pathways.
The key function of ZNF573 Gene Knockout Cell Lines lies in their ability to provide a controlled environment for investigating the role of ZNF573 in transcriptional regulation and its implications in disease models, including cancer and genetic disorders. By observing the effects of ZNF573 absence, scientists can elucidate the gene's contributions to cellular processes, such as proliferation, apoptosis, and response to external stimuli, ultimately advancing our understanding of its biological functions.
In research and clinical settings, ZNF573 knockout models are invaluable for drug screening, biomarker identification, and the development of targeted therapies. These cell lines enable a systematic approach to validate hypotheses regarding ZNF573’s role in pathophysiology, making them essential tools in translational medicine.
One specific advantage of our ZNF573 Gene Knockout Cell Lines over alternatives is the robustness of the CRISPR-generated knockout, which ensures a complete loss of gene function, minimizing off-target effects often seen with older RNAi-based methods. This high specificity enhances the reliability of experimental results, making them more reproducible and meaningful.
For researchers and clinicians focused on gene function analysis and therapeutic discovery, our ZNF573 Gene Knockout Cell Lines provide a crucial platform that accelerates research timelines and fosters innovative breakthroughs. With a commitment to advancing genetic research, our company specializes in high-quality biological products, ensuring that scientists receive unparalleled support and resources to drive their studies forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.